Literature DB >> 26563477

α-Synuclein pathology in the cranial and spinal nerves in Lewy body disease.

Keiko Nakamura1,2, Fumiaki Mori1, Kunikazu Tanji1, Yasuo Miki1, Yasuko Toyoshima3, Akiyoshi Kakita4, Hitoshi Takahashi3, Masahito Yamada2, Koichi Wakabayashi1.   

Abstract

Accumulation of phosphorylated α-synuclein in neurons and glial cells is a histological hallmark of Lewy body disease (LBD) and multiple system atrophy (MSA). Recently, filamentous aggregations of phosphorylated α-synuclein have been reported in the cytoplasm of Schwann cells, but not in axons, in the peripheral nervous system in MSA, mainly in the cranial and spinal nerve roots. Here we conducted an immunohistochemical investigation of the cranial and spinal nerves and dorsal root ganglia of patients with LBD. Lewy axons were found in the oculomotor, trigeminal and glossopharyngeal-vagus nerves, but not in the hypoglossal nerve. The glossopharyngeal-vagus nerves were most frequently affected, with involvement in all of 20 subjects. In the spinal nerve roots, Lewy axons were found in all of the cases examined. Lewy axons in the anterior nerves were more frequent and numerous in the thoracic and sacral segments than in the cervical and lumbar segments. On the other hand, axonal lesions in the posterior spinal nerve roots appeared to increase along a cervical-to-sacral gradient. Although Schwann cell cytoplasmic inclusions were found in the spinal nerves, they were only minimal. In the dorsal root ganglia, axonal lesions were seldom evident. These findings indicate that α-synuclein pathology in the peripheral nerves is axonal-predominant in LBD, whereas it is restricted to glial cells in MSA.
© 2015 Japanese Society of Neuropathology.

Entities:  

Keywords:  Lewy axon; Parkinson's disease; Schwann cell; dorsal root ganglia; α-synuclein

Mesh:

Substances:

Year:  2015        PMID: 26563477     DOI: 10.1111/neup.12269

Source DB:  PubMed          Journal:  Neuropathology        ISSN: 0919-6544            Impact factor:   1.906


  7 in total

1.  Phosphorylated α-synuclein in the retina is a biomarker of Parkinson's disease pathology severity.

Authors:  Isabel Ortuño-Lizarán; Thomas G Beach; Geidy E Serrano; Douglas G Walker; Charles H Adler; Nicolás Cuenca
Journal:  Mov Disord       Date:  2018-05-08       Impact factor: 10.338

2.  Neuropathology of Multiple System Atrophy, a Glioneuronal Degenerative Disease.

Authors:  Koichi Wakabayashi; Yasuo Miki; Kunikazu Tanji; Fumiaki Mori
Journal:  Cerebellum       Date:  2022-04-26       Impact factor: 3.847

Review 3.  Brain Banking for Research into Neurodegenerative Disorders and Ageing.

Authors:  Claire E Shepherd; Holly Alvendia; Glenda M Halliday
Journal:  Neurosci Bull       Date:  2019-01-02       Impact factor: 5.203

4.  Atrophy of the Vagus Nerve in Parkinson's Disease Revealed by High-Resolution Ultrasonography.

Authors:  Uwe Walter; Panagiota Tsiberidou; Maxi Kersten; Alexander Storch; Matthias Löhle
Journal:  Front Neurol       Date:  2018-09-27       Impact factor: 4.003

Review 5.  Autonomic Function in Patients With Parkinson's Disease: From Rest to Exercise.

Authors:  Jeann L Sabino-Carvalho; James P Fisher; Lauro C Vianna
Journal:  Front Physiol       Date:  2021-03-19       Impact factor: 4.566

Review 6.  The role of cardiovascular autonomic failure in the differential diagnosis of α-synucleinopathies.

Authors:  Fabian Leys; Gregor K Wenning; Alessandra Fanciulli
Journal:  Neurol Sci       Date:  2021-11-24       Impact factor: 3.830

7.  High-resolution ultrasound changes of the vagus nerve in idiopathic Parkinson's disease (IPD): a possible additional index of disease.

Authors:  F Sartucci; T Bocci; M Santin; P Bongioanni; G Orlandi
Journal:  Neurol Sci       Date:  2021-04-05       Impact factor: 3.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.